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Abstract
Fistulas in Crohn’s disease are a common problem in treatment of the disease. Especially perianal fistulas may
cause a loss in patient’s quality of life. They are coincident with an unfavourable development of Crohn’s disease.
Because of the frequent young patient's age, they come along with a long life of suffering and high cost for
treatment. Therefore a good clinical diagnostic and a balance between drug therapy and surgery is needed. In this
report, we present the case of a 28-year old male patient with a complex system of fistula in Crohn’s disease. Based
on clinical and radiological findings we performed operative treatment in combination to immunosuppressive therapy
as an interdisciplinary collaboration.
Keywords: Crohn’s disease; Complex system of fistulas; Operative
treatment
Background
Crohn’s disease has an incidence of 6.6 per 100,000 in southern
Germany and is the most common form of inflammatory bowel
disease beside ulcerative colitis [1]. The prevalence can be set at
100-200 per 100,000 [2]. Crohn’s disease is diagnosed mostly during
early adulthood. Accordingly the highest age-specific incidence is
during the third decade of life [3]. This causes yearly expanses due to
direct and indirect costs. Based on the patient’s young age indirect
costs e.g. for non-productive time or pensions are generated. It is
expected, that the indirect costs represent approximately two third
(64%) of the overall cost, whereas the daily drug therapy costs amount
to 69% of the direct costs of 3500 to 6000 euro per patient and year [4].
Therefore early and correct diagnosis, as well as an optimized and
interdisciplinary therapy is essential for a successful treatment.
The diagnosis of Crohn’s disease is made by clinical history,
examination, progression of disease and the combination of
endoscopic, radiologic and blood tests. The initial blood tests should
include leucocytes and C-reactive protein, the amount of iron, renal
function and hepatic function as well. Genetic testing is not necessary.
To exclude a non-inflammatory disease, it is recommended to perform
a testing of faecal inflammatory markers as Calprotectin or Lactoferrin.
These may also be used for follow-up. If there is high suspicion of an
inflammatory bowel disease, an ileocolonoscopy with biopsies should
be made. It should be complemented by esophagogastroduodenoscopy,
if colonoscopy suggested that Crohn’s disease is the probable
underlying disease. A transabdominal and endoanal sonography or a
MRI is made to detect extramural complications as abscesses or
fistulas. To reduce radiation exposure, Computer Tomography (CT)
should be performed in emergency settings solely [5].
To reach an optimal monitoring of disease, the detection of CRP
level or faecal inflammatory markers is useful. This should serve as a
complement to the clinical condition of the patient. Transabdominal
sonography is used as radiological control. In selected cases with
unclear diagnostic findings or suspected complications, MRI,
endosonography or endoscopy may be helpful [5].
Case Presentation
A 28-year old man was diagnosed with Crohn’s disease at the age of
seventeen. Prior to the diagnosis there were multiple surgical excisions
of perianal abscesses and fistulas. Since the age of seventeen, the
patient’s drug therapy consisted of immunosuppressive azathioprine
and 5-aminosalicylic acid and intermittent steroids. In 2011 the first
complex fistula emerging at the right thigh was treated surgically at our
institution. A laparoscopic sigmoidostomy was performed at the same
time to allow the healing of the fistula. Three months later, after
healing of the fistula, the stoma was closed. In the postoperative course
the patient developed a leak of the anastomosis with a colo-cutaneous
fistula. In the emergency CT-scan the left colon showed thickening
consistent with Crohn’s lesions. Therefore we performed revisional
surgery with left colectomy and direct anastomosis. Treatment with
anti-TNF antibodies was recommended after complete healing. This
treatment was never installed.
After an uneventful period of three years, the patient presented to
our emergency department and complained of a progressing reddened
and swollen dorsal right thigh. Despite the absence of fever, the
inflammatory markers were increased with Leucocytes (LC) of 16.7
109/l and C-Reactive Protein (CRP) of 182 mg/l. We diagnosed a
recurrent abscess at the right thigh. The abscess perforated the skin
dorsally and evacuated spontaneously. An antibiotic therapy with
cefuroxime and metronidazole was installed after surgical incision and
drainage of the abscess. In search for a recurrent fistula we performed a
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CT with intravenous contrast medium. It showed a perianal fistula,
with abscess, heading along the semimembranosus muscle (Figure 1).
We decided to perform a Magnetic Resonance Imaging (MRI) of the
right thigh and the pelvis (Figure 2) to explore the dimension of the
fistula. The examination showed a complex system of fistulas along the
ischiocrural muscles with a perforation at the dorsal thigh 10 cm above
the knee, and a submucosal part towards the anus.
Figure 1: Computed Tomography (CT) with axial, sagittal and
coronal plane of the right thigh. (A) The posterior muscle
compartment shows the marginal contrasted abscess and (B) the
fistula heading along the posterior compartment. The perforation is
marked by a star.
Figure 2: Magnetic Resonance Imaging (MRI) of the perianal
region. Axial image showing the fistula at 9 o'clock in lithotomy
position before drainage marked by star.
The patient refused another stoma, for the fear of losing work. We
performed a fistulotomy from the ischial tuberosity to the popliteal
fossa as well as for the submucosal perianal part (Figure 3A). After
radical excision of the affected tissue and splitting of the muscle
compartment, we induced healing of the wound with regular dressing,
until the surface of the wound could be minimized. The perianal part
healed successfully (Figure 3B). The remaining wound was covered
with a split-skin graft taken from the left thigh (Figure 3C). The skin-
transplant healed. Colonoscopy and histology showed changes
consistent with Crohn’s disease. Therefore the antibody therapy with
adalimumab was initiated and the patient was dismissed from the
hospital. Nine month later he presented with a recurrent perianal
abscess in the old wound, which was treated surgically and healed. One
year later the patient was meanwhile treated with adalimumab and
azathioprine. He presented with two new fistulas and ten days later
with a recurrent abscess at the right thigh, all treated surgically. The
follow-up after the last surgery is now five months.
Figure 3: Right posterior thigh after surgical splitting of the fistula.
(A) Proximal is the perianal drainage visible. (B) Wound after
conditioning. (C) Wound after covering with split-skin graft.
Discussion
This patient is challenging, because of the high complexity of his
fistulas. Thereby it is important to diagnose correctly and promptly. To
offer the optimal therapy to the patient it is necessary to act as an
interdisciplinary team during the hospitalisation and afterwards.
The first-line therapy of Crohn’s disease is an immunosuppressive
therapy (azathioprine, methotrexate, TNF-alpha inhibitors). To avoid a
long-term steroidal therapy, it is important to install an
immunosuppressive therapy with other drugs in all patients. Especially
in patients with predictors of an unfavourable development e.g.
smoking, extensive affection of small intestines, young age (<40 years),
perianal affection and use of steroidal drugs at diagnosis, it is essential
to discuss an early installation of immunosuppressive drugs [6]. In
conjunction with surgery an immunosuppressive therapy causes
increased morbidity. It is therefore recommended to discuss
perioperatively an interruption of the therapy, to decrease the rate of
surgical complications like insufficiencies of the anastomosis or sepsis
[7].
A special aspect of Crohn’s disease is the appearance of perianal
fistulas. The appearance of fistulas is combined with a complicated
progress of disease and seriously limits quality of life. However, it is
important to choose an interdisciplinary approach for the treatment
[8]. A fistula should only be treated surgically, when it is symptomatic,
as defined e.g. by pain or secretion. In this case, it is suggested to
perform a seton placement or a fistulotomy [9]. Nevertheless the
operative therapy is limited in complex fistulas. In these rare cases
fistulotomy is not recommended, because of high risk of anal
incontinence [10]. Additionally to the surgery an immunosuppressive
therapy with anti-TNF-alpha antibody should be installed. This
increases the healing of fistulas significantly [11]. Nevertheless the
patients need continuous follow-up with inspection of the fistula and
rectal palpation.
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In the presence of a persistent problem with perianal fistulas with
failure of healing, further surgical procedures may help to control the
perianal situation. The patient may profit from the exclusion of the
fistulas by a surgical stoma [12]. Thereby the extent of the underlying
disease determines the position of the stoma. A relevant part of
patients (10-40%) need a proctectomy, seldom a proctocolectomy as
definitive treatment [13]. Absolute indications for surgery are the
existence of fistulas with short bowel syndrome, fistulas to the vesicle,
high-output fistulas or blind-ending retroperitoneal fistulas [14].
Summarized, it is essential to control patients with Crohn’s disease
regularly and interdisciplinary. Before surgery an exact diagnosis
should be made to offer the best individual treatment for each patient.
Conclusion
With this case report we aim to emphasize the importance of the
diagnostic process in inflammatory bowel disease. Even if
immunosuppressive therapy is the first line therapy for Crohn’s disease,
surgery is needed to control and treat severe complications like
abscesses or fistulas.
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